Witassek Fabienne, Schwenkglenks Matthias, Erne Paul, Radovanovic Dragana
AMIS Plus Data Centre, Institute of Social and Preventive Medicine, University of Zurich, Zurich, Switzerland.
Health Economics Unit, Institute of Social and Preventive Medicine, University of Zurich, Zurich, Switzerland.
Swiss Med Wkly. 2014 Aug 7;144:w13986. doi: 10.4414/smw.2014.13986. eCollection 2014.
The obesity paradox refers to the phenomenon that obese patients seem to have a better outcome than normal weight patients in a variety of disease conditions. The aim of this study was to investigate the impact of Body Mass Index (BMI) on mortality in patients with ST-elevation myocardial infarction (STEMI) who underwent percutaneous coronary intervention (PCI).
Between January 2005 and July 2012, the Swiss AMIS Plus registry enrolled 6,938 patients with acute STEMI who underwent PCI. These patients were stratified into 5 BMI groups according to the classification system of the World Health Organisation. The odds for in-hospital mortality according to BMI groups were analysed using logistic regression with normal weight patients as the reference.
Crude in-hospital mortality rates showed a U-shaped distribution between BMI groups, with the lowest mortality in obese class I patients (2.0%) and the highest mortality in underweight patients (9.0%). The odds for in-hospital mortality were significantly lower for obese class I (OR 0.56; 95% CI 0.35-0.91) and significantly higher for underweight patients (OR 2.72; 95% CI 1.14-6.48) compared to the normal weight group and odds ratios showed a U-shaped distribution. After adjustment for covariates, the odds ratios maintained a U-shape distribution albeit the differences between BMI groups were no longer significant.
This study showed that the lower crude in-hospital mortality of obese class I patients can be partly explained by lower age and lower co-morbidity rates. However, further studies are needed to investigate favourable factors associated with class I obesity.
肥胖悖论是指在多种疾病情况下,肥胖患者似乎比正常体重患者预后更好的现象。本研究的目的是调查体重指数(BMI)对接受经皮冠状动脉介入治疗(PCI)的ST段抬高型心肌梗死(STEMI)患者死亡率的影响。
2005年1月至2012年7月期间,瑞士AMIS Plus注册研究纳入了6938例接受PCI的急性STEMI患者。根据世界卫生组织的分类系统,将这些患者分为5个BMI组。以正常体重患者为参照,采用逻辑回归分析各BMI组的院内死亡几率。
各BMI组的粗院内死亡率呈U形分布,I级肥胖患者死亡率最低(2.0%),体重过轻患者死亡率最高(9.0%)。与正常体重组相比,I级肥胖患者的院内死亡几率显著降低(比值比[OR]0.56;95%置信区间[CI]0.35 - 0.91),体重过轻患者的院内死亡几率显著升高(OR 2.72;95% CI 1.14 - 6.48),且比值比呈U形分布。在对协变量进行调整后,比值比仍保持U形分布,尽管BMI组之间的差异不再显著。
本研究表明,I级肥胖患者较低的粗院内死亡率部分可归因于较低的年龄和较低的合并症发生率。然而,需要进一步研究来调查与I级肥胖相关的有利因素。